229 related articles for article (PubMed ID: 20945416)
1. Loss of tyrosine phosphatase-dependent inhibition promotes activation of tyrosine kinase c-Src in detached pancreatic cells.
Connelly SF; Isley BA; Baker CH; Gallick GE; Summy JM
Mol Carcinog; 2010 Dec; 49(12):1007-21. PubMed ID: 20945416
[TBL] [Abstract][Full Text] [Related]
2. Targeting the yin and the yang: combined inhibition of the tyrosine kinase c-Src and the tyrosine phosphatase SHP-2 disrupts pancreatic cancer signaling and biology in vitro and tumor formation in vivo.
Gomes EG; Connelly SF; Summy JM
Pancreas; 2013 Jul; 42(5):795-806. PubMed ID: 23271399
[TBL] [Abstract][Full Text] [Related]
3. Src homology region 2 (SH2) domain-containing phosphatase-1 dephosphorylates B cell linker protein/SH2 domain leukocyte protein of 65 kDa and selectively regulates c-Jun NH2-terminal kinase activation in B cells.
Mizuno K; Tagawa Y; Mitomo K; Arimura Y; Hatano N; Katagiri T; Ogimoto M; Yakura H
J Immunol; 2000 Aug; 165(3):1344-51. PubMed ID: 10903736
[TBL] [Abstract][Full Text] [Related]
4. Integrin-mediated tyrosine phosphorylation of SHPS-1 and its association with SHP-2. Roles of Fak and Src family kinases.
Tsuda M; Matozaki T; Fukunaga K; Fujioka Y; Imamoto A; Noguchi T; Takada T; Yamao T; Takeda H; Ochi F; Yamamoto T; Kasuga M
J Biol Chem; 1998 May; 273(21):13223-9. PubMed ID: 9582366
[TBL] [Abstract][Full Text] [Related]
5. Src activation regulates anoikis in human colon tumor cell lines.
Windham TC; Parikh NU; Siwak DR; Summy JM; McConkey DJ; Kraker AJ; Gallick GE
Oncogene; 2002 Nov; 21(51):7797-807. PubMed ID: 12420216
[TBL] [Abstract][Full Text] [Related]
6. Regulation of calcium-sensitive tyrosine kinase Pyk2 by angiotensin II in endothelial cells. Roles of Yes tyrosine kinase and tyrosine phosphatase SHP-2.
Tang H; Zhao ZJ; Landon EJ; Inagami T
J Biol Chem; 2000 Mar; 275(12):8389-96. PubMed ID: 10722671
[TBL] [Abstract][Full Text] [Related]
7. Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades.
Lu Y; Yu Q; Liu JH; Zhang J; Wang H; Koul D; McMurray JS; Fang X; Yung WK; Siminovitch KA; Mills GB
J Biol Chem; 2003 Oct; 278(41):40057-66. PubMed ID: 12869565
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidic acid-induced association of SHP-2 with SHPS-1: roles of RHO, FAK, and a SRC family kinase.
Takeda H; Matozaki T; Fujioka Y; Takada T; Noguchi T; Yamao T; Tsuda M; Ochi F; Fukunaga K; Narumiya S; Yamamoto T; Kasuga M
Oncogene; 1998 Jun; 16(23):3019-27. PubMed ID: 9662335
[TBL] [Abstract][Full Text] [Related]
9. Differential effect of the focal adhesion kinase Y397F mutant on v-Src-stimulated cell invasion and tumor growth.
Chang LC; Huang CH; Cheng CH; Chen BH; Chen HC
J Biomed Sci; 2005; 12(4):571-85. PubMed ID: 16132110
[TBL] [Abstract][Full Text] [Related]
10. Fyn kinase-directed activation of SH2 domain-containing protein-tyrosine phosphatase SHP-2 by Gi protein-coupled receptors in Madin-Darby canine kidney cells.
Tang H; Zhao ZJ; Huang XY; Landon EJ; Inagami T
J Biol Chem; 1999 Apr; 274(18):12401-7. PubMed ID: 10212213
[TBL] [Abstract][Full Text] [Related]
11. Protein tyrosine kinase 6 protects cells from anoikis by directly phosphorylating focal adhesion kinase and activating AKT.
Zheng Y; Gierut J; Wang Z; Miao J; Asara JM; Tyner AL
Oncogene; 2013 Sep; 32(36):4304-12. PubMed ID: 23027128
[TBL] [Abstract][Full Text] [Related]
12. Cell-cell contacts prevent anoikis in primary human colonic epithelial cells.
Hofmann C; Obermeier F; Artinger M; Hausmann M; Falk W; Schoelmerich J; Rogler G; Grossmann J
Gastroenterology; 2007 Feb; 132(2):587-600. PubMed ID: 17258732
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine kinase-dependent, phosphatidylinositol 3'-kinase, and mitogen-activated protein kinase-independent signaling pathways prevent lung adenocarcinoma cells from anoikis.
Wei L; Yang Y; Yu Q
Cancer Res; 2001 Mar; 61(6):2439-44. PubMed ID: 11289112
[TBL] [Abstract][Full Text] [Related]
14. Shp-2 mediates v-Src-induced morphological changes and activation of the anti-apoptotic protein kinase Akt.
Hakak Y; Hsu YS; Martin GS
Oncogene; 2000 Jun; 19(28):3164-71. PubMed ID: 10918571
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model.
Trevino JG; Summy JM; Lesslie DP; Parikh NU; Hong DS; Lee FY; Donato NJ; Abbruzzese JL; Baker CH; Gallick GE
Am J Pathol; 2006 Mar; 168(3):962-72. PubMed ID: 16507911
[TBL] [Abstract][Full Text] [Related]
16. Regulation of early events in integrin signaling by protein tyrosine phosphatase SHP-2.
Oh ES; Gu H; Saxton TM; Timms JF; Hausdorff S; Frevert EU; Kahn BB; Pawson T; Neel BG; Thomas SM
Mol Cell Biol; 1999 Apr; 19(4):3205-15. PubMed ID: 10082587
[TBL] [Abstract][Full Text] [Related]
17. Shp2 negatively regulates growth in cardiomyocytes by controlling focal adhesion kinase/Src and mTOR pathways.
Marin TM; Clemente CF; Santos AM; Picardi PK; Pascoal VD; Lopes-Cendes I; Saad MJ; Franchini KG
Circ Res; 2008 Oct; 103(8):813-24. PubMed ID: 18757826
[TBL] [Abstract][Full Text] [Related]
18. Expression and activity of SRC regulate interleukin-8 expression in pancreatic adenocarcinoma cells: implications for angiogenesis.
Trevino JG; Summy JM; Gray MJ; Nilsson MB; Lesslie DP; Baker CH; Gallick GE
Cancer Res; 2005 Aug; 65(16):7214-22. PubMed ID: 16103072
[TBL] [Abstract][Full Text] [Related]
19. Activation of SRC tyrosine kinases in response to ICAM-1 ligation in pulmonary microvascular endothelial cells.
Wang Q; Pfeiffer GR; Gaarde WA
J Biol Chem; 2003 Nov; 278(48):47731-43. PubMed ID: 14504278
[TBL] [Abstract][Full Text] [Related]
20. Src tyrosine kinase inhibitor PP2 suppresses ERK1/2 activation and epidermal growth factor receptor transactivation by X-irradiation.
Li Z; Hosoi Y; Cai K; Tanno Y; Matsumoto Y; Enomoto A; Morita A; Nakagawa K; Miyagawa K
Biochem Biophys Res Commun; 2006 Mar; 341(2):363-8. PubMed ID: 16414009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]